In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics, continues to advance its product portfolio and market presence in 2025. A key growth driver is its droplet digital PCR (ddPCR) platform, led by the QX600 system. The company recently acquired Stilla Technologies to enhance ddPCR capabilities and enter new ...